Information Blocking: Simplifying the New Enforcement Rules

Healthcare11/15/2023 7:00 PM

Go to Registration Page

Description

This session will offer an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law. Session: Wednesday, November 15, 2:00 PM — 3:00 PM EST This webinar will discuss the 21st Century Cures Act (the Cures Act); how it was designed to improve patient access to medical records and promote seamless communication across healthcare providers. The speakers will focus on the strict rules prohibiting information blocking, which can interfere with, prevent, or discourage access, exchange, or use of Electronic Health Information (EHI). This webinar will explain how information blocking regulations do not mandate healthcare providers to adopt or use specific technologies or platforms to make EHI available for access, exchange, or use. The speakers will describe the range of technologies and platforms available to share patient data. They will also provide examples of how some health IT vendors may be prohibiting certain technologies or charging users punitive fees to discourage use of certain technologies, activities which may constitute information blocking. The audience will gain an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law. The talk will provide the audience with information needed to comply with information blocking regulations, inform them of ways health IT vendors may be performing information blocking, and the appropriate actions labs may take to address potential information blocking activity.

Comments

Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar

Publisher

G2 Intelligence

G2 Intelligence

G2 Intelligence is a business intelligence platform for the Lab Diagnostics industry. We offer monthly reports covering science & technology, compliance, business, and legislation & regulations. Our reports keep you up-to-date on new diagnostic tests, testing trends, opportunities, emerging test technologies, lab business and competitive strategy, market trends, M&A and investment activity, as well as federal and state laws, regulations, new legislation, and court cases that affect your diagnostic lab or pathology practice.